Back to Search
Start Over
Junin Virus Triggers Macrophage Activation and Modulates Polarization According to Viral Strain Pathogenicity
- Source :
- Frontiers in Immunology, Vol 10 (2019), CONICET Digital (CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, instacron:CONICET, Frontiers in Immunology, SEDICI (UNLP), Universidad Nacional de La Plata, instacron:UNLP
- Publication Year :
- 2019
- Publisher :
- Frontiers Media S.A., 2019.
-
Abstract
- The New World arenavirus Junin (JUNV) is the etiological agent of Argentine hemorrhagic fever (AHF). Previous studies of human macrophage infection by the Old-World arenaviruses Mopeia and Lassa showed that while the non-pathogenic Mopeia virus replicates and activates human macrophages, the pathogenic Lassa virus replicates but fails to activate human macrophages. Less is known in regard to the impact of New World arenavirus infection on the human macrophage immune response. Macrophage activation is critical for controlling infections but could also be usurped favoring immune evasion. Therefore, it is crucial to understand how the JUNV infection modulates macrophage plasticity to clarify its role in AHF pathogenesis. With this aim in mind, we compared infection with the attenuated Candid 1 (C#1) or the pathogenic P strains of the JUNV virus in human macrophage cultures. The results showed that both JUNV strains similarly replicated and induced morphological changes as early as 1 day post-infection. However, both strains differentially induced the expression of CD71, the receptor for cell entry, the activation and maturation molecules CD80, CD86, and HLA-DR and selectively modulated cytokine production. Higher levels of TNF-α, IL-10, and IL-12 were detected with C#1 strain, while the P strain induced only higher levels of IL-6. We also found that C#1 strain infection skewed macrophage polarization to M1, whereas the P strain shifted the response to an M2 phenotype. Interestingly, the MERTK receptor, that negatively regulates the immune response, was down-regulated by C#1 strain and up-regulated by P strain infection. Similarly, the target genes of MERTK activation, the cytokine suppressors SOCS1 and SOCS3, were also increased after P strain infection, in addition to IRF-1, that regulates type I IFN levels, which were higher with C#1 compared with P strain infection. Together, this differential activation/polarization pattern of macrophages elicited by P strain suggests a more evasive immune response and may have important implications in the pathogenesis of AHF and underpinning the development of new potential therapeutic strategies<br />Facultad de Ciencias Exactas<br />Instituto de Biotecnologia y Biologia Molecular<br />Centro de Investigación y Desarrollo en Fermentaciones Industriales
- Subjects :
- 0301 basic medicine
medicine.medical_treatment
Biología
Biotecnología relacionada con la Salud
MACROPHAGE ACTIVATION
medicine.disease_cause
0302 clinical medicine
Cricetinae
Chlorocebus aethiops
Immunology and Allergy
purl.org/becyt/ford/3.4 [https]
Original Research
human macrophages
junin virus
Cytokine
TAM RECEPTORS
B7-1 Antigen
Cytokines
purl.org/becyt/ford/3 [https]
MACROPHAGE POLARIZATION
lcsh:Immunologic diseases. Allergy
CIENCIAS MÉDICAS Y DE LA SALUD
macrophage polarization
Immunology
Macrophage polarization
Biology
Argentine hemorrhagic fever
TAM receptors
Hemorrhagic Fever, American
HUMAN MACROPHAGES
Virus
Biotecnología de la Salud
Microbiology
03 medical and health sciences
Immune system
Species Specificity
macrophage activation
medicine
Animals
Humans
Vero Cells
Ciencias Exactas
Macrophages
HLA-DR Antigens
MERTK
medicine.disease
biology.organism_classification
030104 developmental biology
Lassa virus
Junin virus
Ciencias Médicas
IFN-I
B7-2 Antigen
lcsh:RC581-607
JUNIN VIRUS
030215 immunology
Subjects
Details
- Language :
- English
- ISSN :
- 16643224
- Volume :
- 10
- Database :
- OpenAIRE
- Journal :
- Frontiers in Immunology
- Accession number :
- edsair.doi.dedup.....32607f60f886d5b42fe5ed6fede99a08
- Full Text :
- https://doi.org/10.3389/fimmu.2019.02499/full